RE:RE:RE:$BEV given amendment to use sensory evaluations in trials! Honestly, they don't really atract new capital at all. They merely dilute shareholders continuously by using the share count as their own revolving ATM.
Even the investments into the company at $1.50 was from monies they borrowed from Naturo, because it was private, shareholders in Bevcanna weren't aware of these transactions until after the financials came out.
It is extremely deceptive behind closed door decisions (with zero shareholder approval) in which they constantly line their own pockets at shareholders expense.